Literature DB >> 23570386

A death-promoting role for ISG54/IFIT2.

Nancy C Reich1.   

Abstract

The cellular responses to infection are many, and include programmed cell death to inhibit microbial dissemination and the production and secretion of interferons (IFNs), which confer resistance to uninfected cells. In addition to the antimicrobial effects of IFNs, these cytokines have been used clinically for the treatment of various neoplasias to inhibit proliferation and stimulate apoptosis. However, the precise mechanisms of action of IFNs remain to be completely understood. One of the primary response genes induced after an infection or treatment with type I or III IFN is known as IFN-stimulated gene 54 (ISG54) or IFN-induced gene with tetratricopeptide repeats 2 (IFIT2). ISG54/IFIT2 is a member of a family of IFN-induced genes related in the sequence and structure. Expression of this protein has been found to promote cellular apoptosis by a mitochondrial pathway dependent on the action of Bcl2 proteins. ISG54/IFIT2 does not function as a monomer, and it forms complexes with itself and with the related ISG56/IFIT1 and ISG60/IFIT3 proteins to elicit complex cellular responses. The apoptotic response to ISG54/IFIT2 may contribute to other functions that have been reported, including translational regulation, inhibition of tumor colonization, and protection against a lethal viral infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23570386      PMCID: PMC3624773          DOI: 10.1089/jir.2012.0159

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  67 in total

Review 1.  The tetratricopeptide repeat: a structural motif mediating protein-protein interactions.

Authors:  G L Blatch; M Lässle
Journal:  Bioessays       Date:  1999-11       Impact factor: 4.345

2.  Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56.

Authors:  Fulvia Terenzi; Daniel J Hui; William C Merrick; Ganes C Sen
Journal:  J Biol Chem       Date:  2006-09-13       Impact factor: 5.157

Review 3.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

4.  Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L.

Authors:  A Zhou; J Paranjape; T L Brown; H Nie; S Naik; B Dong; A Chang; B Trapp; R Fairchild; C Colmenares; R H Silverman
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

5.  Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.

Authors:  M Yoneyama; W Suhara; Y Fukuhara; M Fukuda; E Nishida; T Fujita
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

6.  Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1.

Authors:  B K Weaver; K P Kumar; N C Reich
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

Review 7.  PKR, apoptosis and cancer.

Authors:  R Jagus; B Joshi; G N Barber
Journal:  Int J Biochem Cell Biol       Date:  1999-01       Impact factor: 5.085

8.  Induction and mode of action of the viral stress-inducible murine proteins, P56 and P54.

Authors:  Fulvia Terenzi; Srabani Pal; Ganes C Sen
Journal:  Virology       Date:  2005-09-15       Impact factor: 3.616

9.  PML is essential for multiple apoptotic pathways.

Authors:  Z G Wang; D Ruggero; S Ronchetti; S Zhong; M Gaboli; R Rivi; P P Pandolfi
Journal:  Nat Genet       Date:  1998-11       Impact factor: 38.330

10.  Distinct STAT structure promotes interaction of STAT2 with the p48 subunit of the interferon-alpha-stimulated transcription factor ISGF3.

Authors:  M Martinez-Moczygemba; M J Gutch; D L French; N C Reich
Journal:  J Biol Chem       Date:  1997-08-08       Impact factor: 5.157

View more
  38 in total

1.  MAVS-dependent host species range and pathogenicity of human hepatitis A virus.

Authors:  Asuka Hirai-Yuki; Lucinda Hensley; David R McGivern; Olga González-López; Anshuman Das; Hui Feng; Lu Sun; Justin E Wilson; Fengyu Hu; Zongdi Feng; William Lovell; Ichiro Misumi; Jenny P-Y Ting; Stephanie Montgomery; John Cullen; Jason K Whitmire; Stanley M Lemon
Journal:  Science       Date:  2016-09-15       Impact factor: 47.728

2.  The LIM protein AJUBA promotes colorectal cancer cell survival through suppression of JAK1/STAT1/IFIT2 network.

Authors:  H Jia; L Song; Q Cong; J Wang; H Xu; Y Chu; Q Li; Y Zhang; X Zou; C Zhang; Y E Chin; X Zhang; Z Li; K Zhu; B Wang; H Peng; Z Hou
Journal:  Oncogene       Date:  2016-11-28       Impact factor: 9.867

3.  Critical roles for Rictor/Sin1 complexes in interferon-dependent gene transcription and generation of antiproliferative responses.

Authors:  Surinder Kaur; Barbara Kroczynska; Bhumika Sharma; Antonella Sassano; Ahmet Dirim Arslan; Beata Majchrzak-Kita; Brady L Stein; Brandon McMahon; Jessica K Altman; Bing Su; Raffaele A Calogero; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2014-01-27       Impact factor: 5.157

Review 4.  Innate Immunity to Enteric Hepatitis Viruses.

Authors:  Zongdi Feng; Stanley M Lemon
Journal:  Cold Spring Harb Perspect Med       Date:  2019-03-01       Impact factor: 6.915

5.  Quantitative profiling of innate immune activation by viral infection in single cells.

Authors:  Andrea C Timm; Jay W Warrick; John Yin
Journal:  Integr Biol (Camb)       Date:  2017-09-18       Impact factor: 2.192

6.  Curcumin induces apoptosis in human leukemic cell lines through an IFIT2-dependent pathway.

Authors:  Yonglu Zhang; Yunyuan Kong; Shuyuan Liu; Lingbing Zeng; Lagen Wan; Zhanglin Zhang
Journal:  Cancer Biol Ther       Date:  2017-01-10       Impact factor: 4.742

7.  Adenovirus small E1A employs the lysine acetylases p300/CBP and tumor suppressor Rb to repress select host genes and promote productive virus infection.

Authors:  Roberto Ferrari; Dawei Gou; Gauri Jawdekar; Sarah A Johnson; Miguel Nava; Trent Su; Ahmed F Yousef; Nathan R Zemke; Matteo Pellegrini; Siavash K Kurdistani; Arnold J Berk
Journal:  Cell Host Microbe       Date:  2014-11-12       Impact factor: 21.023

Review 8.  Murine Models of Hepatitis A Virus Infection.

Authors:  Asuka Hirai-Yuki; Jason K Whitmire; Michael Joyce; D Lorne Tyrrell; Stanley M Lemon
Journal:  Cold Spring Harb Perspect Med       Date:  2019-01-02       Impact factor: 6.915

9.  Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.

Authors:  Jianjun Gao; Lewis Zhichang Shi; Hao Zhao; Jianfeng Chen; Liangwen Xiong; Qiuming He; Tenghui Chen; Jason Roszik; Chantale Bernatchez; Scott E Woodman; Pei-Ling Chen; Patrick Hwu; James P Allison; Andrew Futreal; Jennifer A Wargo; Padmanee Sharma
Journal:  Cell       Date:  2016-09-22       Impact factor: 41.582

Review 10.  Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid Tumors.

Authors:  Eric D Brooks; Jonathan E Schoenhals; Chad Tang; Goran Micevic; Daniel R Gomez; Joe Y Chang; James W Welsh
Journal:  Cancer J       Date:  2016 Jul-Aug       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.